sec filing
NR
NASDAQ · NRXS
NeurAxis, Inc.
Healthcare · Biotechnology
$7.13
Down-$0.42 (-5.56%)
Updated Nov 2, 2026, 10:32 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.12M
- P/E ratio
- -3.46
- Dividend yield
- 0.00%
- 52-week range
- $2.21 – $9.33
- Volume
- 150.39K
- Avg. volume
- 388.77K
Price performance · NRXS
NRXS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NRXS closed at $7.13 after 20 trading sessions, down 0.28% for the selected period.
- Last close
- $7.13
- Period change
- -0.28%
- Period low
- $6.50
- Period high
- $7.92
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $7.49 | $7.49 | $7.02 | $7.13 | 150.39K |
| Oct 29, 2026 | $7.65 | $7.735 | $7.4235 | $7.55 | 90.58K |
| Oct 28, 2026 | $7.30 | $7.59 | $7.17 | $7.57 | 73.28K |
| Oct 27, 2026 | $7.31 | $7.60 | $7.31 | $7.36 | 38.92K |
| Oct 26, 2026 | $7.39 | $7.5079 | $7.25 | $7.25 | 84.85K |
| Oct 23, 2026 | $7.57 | $7.68 | $7.36 | $7.40 | 75.21K |
| Oct 22, 2026 | $7.87 | $7.87 | $7.44 | $7.60 | 86.95K |
| Oct 21, 2026 | $7.84 | $8.05 | $7.715 | $7.92 | 66.94K |
| Oct 20, 2026 | $7.86 | $8.00 | $7.75 | $7.82 | 57.88K |
| Oct 19, 2026 | $7.72 | $7.94 | $7.24 | $7.85 | 194.23K |
| Oct 16, 2026 | $7.66 | $7.82 | $7.40 | $7.70 | 229.38K |
| Oct 15, 2026 | $6.87 | $7.84 | $6.80 | $7.74 | 1.13M |
| Oct 14, 2026 | $6.44 | $6.635 | $6.00 | $6.53 | 173.09K |
| Oct 13, 2026 | $6.65 | $6.75 | $6.40 | $6.50 | 118.08K |
| Oct 12, 2026 | $6.86 | $6.86 | $6.55 | $6.72 | 74.64K |
| Oct 9, 2026 | $6.96 | $7.05 | $6.79 | $6.93 | 56.73K |
| Oct 8, 2026 | $6.81 | $6.99 | $6.67 | $6.77 | 30.01K |
| Oct 7, 2026 | $6.72 | $7.035 | $6.60 | $6.83 | 66.06K |
| Oct 6, 2026 | $7.20 | $7.31 | $6.76 | $6.78 | 66.54K |
| Oct 5, 2026 | $7.15 | $7.40 | $7.065 | $7.15 | 53.78K |
Latest NRXS news
The latest Smart Investors Daily articles mentioning NRXS.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

